Clinical Trials Browser

Phase 1 × OTHER × Ganglioneuroblastoma × Clear all

NCT02311621 2025-05-28

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

Phase 1 Active not recruiting

Neuroblastoma, Ganglioneuroblastoma